Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
by
Zhou, Fuling
, Zhang, Haojian
, Yu, Yalan
, Liu, Minghui
, Zhang, Ruixian
, Zhou, Yi
, Wang, Xinghuan
, Liu, Yanan
, Shao, Liang
, Li, Xinyi
in
Blood
/ complete clinical course
/ COVID-19
/ Diabetes
/ Diarrhea
/ Disease progression
/ Disease transmission
/ Dyspnea
/ Epidemics
/ Fever
/ Hospitalization
/ Hospitals
/ Hypertension
/ Illnesses
/ Infectious diseases
/ Influenza
/ Leukocytes
/ Lymphocytes
/ Medicine
/ Mortality
/ Neutrophils
/ non-survivor
/ Nosocomial infections
/ Patients
/ Pneumonia
/ SARS-CoV-2
/ Seafood
/ Severe acute respiratory syndrome coronavirus 2
/ Statistical analysis
/ Viruses
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
by
Zhou, Fuling
, Zhang, Haojian
, Yu, Yalan
, Liu, Minghui
, Zhang, Ruixian
, Zhou, Yi
, Wang, Xinghuan
, Liu, Yanan
, Shao, Liang
, Li, Xinyi
in
Blood
/ complete clinical course
/ COVID-19
/ Diabetes
/ Diarrhea
/ Disease progression
/ Disease transmission
/ Dyspnea
/ Epidemics
/ Fever
/ Hospitalization
/ Hospitals
/ Hypertension
/ Illnesses
/ Infectious diseases
/ Influenza
/ Leukocytes
/ Lymphocytes
/ Medicine
/ Mortality
/ Neutrophils
/ non-survivor
/ Nosocomial infections
/ Patients
/ Pneumonia
/ SARS-CoV-2
/ Seafood
/ Severe acute respiratory syndrome coronavirus 2
/ Statistical analysis
/ Viruses
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
by
Zhou, Fuling
, Zhang, Haojian
, Yu, Yalan
, Liu, Minghui
, Zhang, Ruixian
, Zhou, Yi
, Wang, Xinghuan
, Liu, Yanan
, Shao, Liang
, Li, Xinyi
in
Blood
/ complete clinical course
/ COVID-19
/ Diabetes
/ Diarrhea
/ Disease progression
/ Disease transmission
/ Dyspnea
/ Epidemics
/ Fever
/ Hospitalization
/ Hospitals
/ Hypertension
/ Illnesses
/ Infectious diseases
/ Influenza
/ Leukocytes
/ Lymphocytes
/ Medicine
/ Mortality
/ Neutrophils
/ non-survivor
/ Nosocomial infections
/ Patients
/ Pneumonia
/ SARS-CoV-2
/ Seafood
/ Severe acute respiratory syndrome coronavirus 2
/ Statistical analysis
/ Viruses
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
Journal Article
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Background . The outbreak of COVID-19 has attracted the attention of the whole world. Our study aimed to describe illness progression and risk profiles for mortality in non-survivors.Methods . We retrospectively analyzed 155 patients with COVID-19 in Wuhan and focused on 18 non-survivors among them. Briefly, we compared the dynamic profile of biochemical and immune parameters and drew an epidemiological and clinical picture of disease progression from disease onset to death in non-survivors. The survival status of the cohort was indicated by a Kaplan–Meier curve.Results . Of the non-survivors, the median age was 73.5 years, and the proportion of males was 72.2%. Five and 13 patients were hospital-acquired and community-acquired infection of SARS-CoV-2, respectively. The interval between disease onset and diagnosis was 8.5 days (IQR, [4–11]). With the deterioration of disease, most patients experienced consecutive changes in biochemical parameters, including lymphopenia, leukocytosis, thrombocytopenia, hypoproteinemia, as well as elevated D-dimer and procalcitonin. Regarding the immune dysregulation, patients exhibited significantly decreased T lymphocytes in the peripheral blood, including CD3+T, CD3+CD4+Th, and CD3+CD8+Tc cells. By the end of the disease, most patients suffered from severe complications, including ARDS (17/18; 94.4%), acute cardiac injury (10/18; 55.6%), acute kidney injury (7/18; 38.9%), shock (6/18; 33.3%), gastrointestinal bleeding (1/18; 5.6%), as well as perforation of intestine (1/18; 5.6%). All patients died within 45 days after the initial hospital admission with a median survivor time of 13.5 days (IQR, 8–17).Conclusions . Our data show that patients experienced consecutive changes in biochemical and immune parameters with the deterioration of the disease, indicating the necessity of early intervention.
This website uses cookies to ensure you get the best experience on our website.